Purisal
Tablet
Generic Name
Levosalbutamol
Manufacturer
Incepta Pharmaceuticals Ltd.
Unit Price
Unit Price: ৳ 1.00 (10 x 10: ৳ 100.00) Strip Price: ৳ 10.00
🔹 Indications
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Pharmacology
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Dosage & Administration
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Interaction
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Contraindications
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Side Effects
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Pregnancy & Lactation
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Precautions & Warnings
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
🔹 Storage Conditions
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
💡 Frequently Asked Questions
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
Purisal is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease.
User Reviews
⭐
No reviews yet!
Be the first to share your experience.